CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure

Kenta Tsunekuni, Masamitsu Konno, Naotsugu Haraguchi, Jun Koseki, Ayumu Asai, Kazuaki Matsuoka, Takashi Kobunai, Teiji Takechi, Yuichiro Doki, Masaki Mori, Hideshi Ishii

研究成果: ジャーナルへの寄稿記事

抄録

Cancer stem cells (CSCs) are involved in metastatic colorectal cancer recurrence, but no effective therapy targeting these cells is currently available. Because trifluridine (FTD)/tipiracil therapy is used for refractory colorectal cancer, we sought to determine whether FTD is effective against CSC-like cells. CD44+CD133+ high-expressing and other populations of human DLD-1 colon cancer cells were separately isolated through fluorescence-activated cell sorting. The sphere-forming activity of each population and the anti-sphere-forming effects of FTD and fluorouracil (5-FU) on CD44+CD133+ cells were then measured. CD44+CD133+ DLD-1 cells formed substantially more spheres than other cells. Moreover, treating CD44+CD133+ DLD-1 cells with subtoxic concentrations of FTD (1 µM) inhibited sphere formation, and this was superior to the effect of subtoxic concentrations (1 µM) of 5-FU. The associated inhibition rates for FTD and 5-FU were 58.2% and 26.1%, respectively. Further, CD44+CD133+ DLD-1 cells expressed higher levels of thymidine kinase 1, which is responsible for FTD phosphorylation, than DLD-1 cells, and FTD was incorporated into the DNA of CD44+CD133+ DLD-1 cells. Thus, our data show that FTD treatment is effective against CSC-like cells and might be applied as CSC-targeting chemotherapy for tumor subtypes with high CD44 and CD133 expression.

元の言語英語
記事番号14861
ジャーナルScientific reports
9
発行部数1
DOI
出版物ステータス出版済み - 12 1 2019

Fingerprint

Trifluridine
Neoplastic Stem Cells
Colorectal Neoplasms
Fluorouracil
Cell- and Tissue-Based Therapy
Colonic Neoplasms
Population
Flow Cytometry

All Science Journal Classification (ASJC) codes

  • General

これを引用

Tsunekuni, K., Konno, M., Haraguchi, N., Koseki, J., Asai, A., Matsuoka, K., ... Ishii, H. (2019). CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure. Scientific reports, 9(1), [14861]. https://doi.org/10.1038/s41598-019-50968-6

CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure. / Tsunekuni, Kenta; Konno, Masamitsu; Haraguchi, Naotsugu; Koseki, Jun; Asai, Ayumu; Matsuoka, Kazuaki; Kobunai, Takashi; Takechi, Teiji; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi.

:: Scientific reports, 巻 9, 番号 1, 14861, 01.12.2019.

研究成果: ジャーナルへの寄稿記事

Tsunekuni, K, Konno, M, Haraguchi, N, Koseki, J, Asai, A, Matsuoka, K, Kobunai, T, Takechi, T, Doki, Y, Mori, M & Ishii, H 2019, 'CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure', Scientific reports, 巻. 9, 番号 1, 14861. https://doi.org/10.1038/s41598-019-50968-6
Tsunekuni K, Konno M, Haraguchi N, Koseki J, Asai A, Matsuoka K その他. CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure. Scientific reports. 2019 12 1;9(1). 14861. https://doi.org/10.1038/s41598-019-50968-6
Tsunekuni, Kenta ; Konno, Masamitsu ; Haraguchi, Naotsugu ; Koseki, Jun ; Asai, Ayumu ; Matsuoka, Kazuaki ; Kobunai, Takashi ; Takechi, Teiji ; Doki, Yuichiro ; Mori, Masaki ; Ishii, Hideshi. / CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure. :: Scientific reports. 2019 ; 巻 9, 番号 1.
@article{bf7c898d1f3e4b11bdcf74123f5881e6,
title = "CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure",
abstract = "Cancer stem cells (CSCs) are involved in metastatic colorectal cancer recurrence, but no effective therapy targeting these cells is currently available. Because trifluridine (FTD)/tipiracil therapy is used for refractory colorectal cancer, we sought to determine whether FTD is effective against CSC-like cells. CD44+CD133+ high-expressing and other populations of human DLD-1 colon cancer cells were separately isolated through fluorescence-activated cell sorting. The sphere-forming activity of each population and the anti-sphere-forming effects of FTD and fluorouracil (5-FU) on CD44+CD133+ cells were then measured. CD44+CD133+ DLD-1 cells formed substantially more spheres than other cells. Moreover, treating CD44+CD133+ DLD-1 cells with subtoxic concentrations of FTD (1 µM) inhibited sphere formation, and this was superior to the effect of subtoxic concentrations (1 µM) of 5-FU. The associated inhibition rates for FTD and 5-FU were 58.2{\%} and 26.1{\%}, respectively. Further, CD44+CD133+ DLD-1 cells expressed higher levels of thymidine kinase 1, which is responsible for FTD phosphorylation, than DLD-1 cells, and FTD was incorporated into the DNA of CD44+CD133+ DLD-1 cells. Thus, our data show that FTD treatment is effective against CSC-like cells and might be applied as CSC-targeting chemotherapy for tumor subtypes with high CD44 and CD133 expression.",
author = "Kenta Tsunekuni and Masamitsu Konno and Naotsugu Haraguchi and Jun Koseki and Ayumu Asai and Kazuaki Matsuoka and Takashi Kobunai and Teiji Takechi and Yuichiro Doki and Masaki Mori and Hideshi Ishii",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-019-50968-6",
language = "English",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure

AU - Tsunekuni, Kenta

AU - Konno, Masamitsu

AU - Haraguchi, Naotsugu

AU - Koseki, Jun

AU - Asai, Ayumu

AU - Matsuoka, Kazuaki

AU - Kobunai, Takashi

AU - Takechi, Teiji

AU - Doki, Yuichiro

AU - Mori, Masaki

AU - Ishii, Hideshi

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Cancer stem cells (CSCs) are involved in metastatic colorectal cancer recurrence, but no effective therapy targeting these cells is currently available. Because trifluridine (FTD)/tipiracil therapy is used for refractory colorectal cancer, we sought to determine whether FTD is effective against CSC-like cells. CD44+CD133+ high-expressing and other populations of human DLD-1 colon cancer cells were separately isolated through fluorescence-activated cell sorting. The sphere-forming activity of each population and the anti-sphere-forming effects of FTD and fluorouracil (5-FU) on CD44+CD133+ cells were then measured. CD44+CD133+ DLD-1 cells formed substantially more spheres than other cells. Moreover, treating CD44+CD133+ DLD-1 cells with subtoxic concentrations of FTD (1 µM) inhibited sphere formation, and this was superior to the effect of subtoxic concentrations (1 µM) of 5-FU. The associated inhibition rates for FTD and 5-FU were 58.2% and 26.1%, respectively. Further, CD44+CD133+ DLD-1 cells expressed higher levels of thymidine kinase 1, which is responsible for FTD phosphorylation, than DLD-1 cells, and FTD was incorporated into the DNA of CD44+CD133+ DLD-1 cells. Thus, our data show that FTD treatment is effective against CSC-like cells and might be applied as CSC-targeting chemotherapy for tumor subtypes with high CD44 and CD133 expression.

AB - Cancer stem cells (CSCs) are involved in metastatic colorectal cancer recurrence, but no effective therapy targeting these cells is currently available. Because trifluridine (FTD)/tipiracil therapy is used for refractory colorectal cancer, we sought to determine whether FTD is effective against CSC-like cells. CD44+CD133+ high-expressing and other populations of human DLD-1 colon cancer cells were separately isolated through fluorescence-activated cell sorting. The sphere-forming activity of each population and the anti-sphere-forming effects of FTD and fluorouracil (5-FU) on CD44+CD133+ cells were then measured. CD44+CD133+ DLD-1 cells formed substantially more spheres than other cells. Moreover, treating CD44+CD133+ DLD-1 cells with subtoxic concentrations of FTD (1 µM) inhibited sphere formation, and this was superior to the effect of subtoxic concentrations (1 µM) of 5-FU. The associated inhibition rates for FTD and 5-FU were 58.2% and 26.1%, respectively. Further, CD44+CD133+ DLD-1 cells expressed higher levels of thymidine kinase 1, which is responsible for FTD phosphorylation, than DLD-1 cells, and FTD was incorporated into the DNA of CD44+CD133+ DLD-1 cells. Thus, our data show that FTD treatment is effective against CSC-like cells and might be applied as CSC-targeting chemotherapy for tumor subtypes with high CD44 and CD133 expression.

UR - http://www.scopus.com/inward/record.url?scp=85073446365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073446365&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-50968-6

DO - 10.1038/s41598-019-50968-6

M3 - Article

C2 - 31619711

AN - SCOPUS:85073446365

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 14861

ER -